Kanada - enska - Health Canada

mint pharmaceuticals inc - labetalol hydrochloride - tablet - 200mg - labetalol hydrochloride 200mg - beta-adrenergic blocking agents

Kanada - enska - Health Canada

apotex inc - labetalol hydrochloride - tablet - 100mg - labetalol hydrochloride 100mg - beta-adrenergic blocking agents

Kanada - enska - Health Canada

apotex inc - labetalol hydrochloride - tablet - 200mg - labetalol hydrochloride 200mg - beta-adrenergic blocking agents

Bandaríkin - enska - NLM (National Library of Medicine)

a-s medication solutions - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride tablets are indicated in the management of hypertension. labetalol hydrochloride tablets may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics. labetalol hydrochloride tablets are contraindicated in bronchial asthma, overt cardiac failure, greater-than-first-degree heart block, cardiogenic shock, severe bradycardia, other conditions associated with severe and prolonged hypotension, and in patients with a history of hypersensitivity to any component of the product (see warnings). beta-blockers, even those with apparent cardioselectivity, should not be used in patients with a history of obstructive airway disease, including asthma.

Bandaríkin - enska - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - labetalol (unii: r5h8897n95) (labetalol - unii:r5h8897n95) - labetalol 100 mg

Bandaríkin - enska - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hcl injection is indicated in severe hypertension, to lower blood pressure. labetalol hydrochloride injection iscontraindicated in patients with: - bronchial asthma or obstructive airway disease. - severe sinus bradycardia: - heart block greater than first degree. - cardiogenic shock. - iv administration of non-dihydropyridine calcium-channel antagonists (e.g., verapamil) - hypersensitivity reactions, including anaphylaxis, to labetalol risk summary the extensive experience with use of labetalol in pregnant women, based on published interventional and observational studies, has not identified a drug-associated risk for major birth defects, miscarriage, or adverse maternal or fetal outcomes (see data). untreated hypertension during pregnancy can lead to serious adverse outcomes for the mother and the fetus (see clinical considerations) . in animal reproduction studies, oral administration of labetalol to pregnant rats and rabbits during organogenesis at doses up to approximately six and four times t

Bandaríkin - enska - NLM (National Library of Medicine)

unit dose services - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 100 mg

Bandaríkin - enska - NLM (National Library of Medicine)

remedyrepack inc. - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 100 mg

Bandaríkin - enska - NLM (National Library of Medicine)

remedyrepack inc. - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 100 mg

Bandaríkin - enska - NLM (National Library of Medicine)

remedyrepack inc. - labetalol hydrochloride (unii: 1gev3baw9j) (labetalol - unii:r5h8897n95) - labetalol hydrochloride 100 mg